INTRODUCTION
Transferrin receptor 1 (TfR) is a widely expressed type II membrane protein that plays a central role in iron metabolism. Its ligand, transferrin (Tf), binds ferric iron with high affinity to solubilize it, render it non-reactive, and deliver it to cells. At the cell surface, holotransferrin (Fe 2 -Tf) binds to TfR and is internalized by receptor-mediated endocytosis. Fe dissociates from Tf within acidified endosomes and is transferred across the endosomal membrane by divalent metal transporter 1 (DMT1; reviewed in ref. 1) . The apoTf-TfR complex is then recycled back to the cell surface. This process, termed the Tf cycle, is reiterated many times by each TfR and Tf molecule, providing a highly efficient mechanism for cellular iron uptake.
The erythroid bone marrow requires an exceptionally large amount of iron to support the production of hemoglobin. However, other cells that are not actively dividing have minimal iron requirements. Accordingly, two mutant mouse strains, deficient in TfR or Tf, have revealed a critical role for the Tf cycle in erythropoiesis. Embryos lacking TfR appear to form nonhematopoietic tissues normally during early embryogenesis, but die from severe anemia at midgestation, indicating that they become dependent upon the Tf cycle prior to the onset of fetal liver hematopoiesis. 2 The fact that TfR -/-embryos can produce a substantial red cell mass until embryonic day 10.5 (E10.5) suggests that TfR-independent mechanisms of iron uptake are adequate for the earliest erythropoiesis as well as for the initial formation of most tissues.
Similarly, hypotransferrinemic (Tf hpx/hpx ) animals are profoundly anemic due to an inactivating mutation within a splice donor site in the Tf gene. 3 They also appear to have normal only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From development of most non-hematopoietic tissues. Tf hpx/hpx mice survive if they are given exogenous Tf or red blood cell transfusions soon after birth. 4 Interestingly, these animals develop systemic iron overload similar to human patients with atransferrinemia, 5 providing further evidence that the Tf cycle may be dispensable for the survival, proliferation and differentiation of many cell types. However, TfR -/-mice and Tf hpx/hpx mice show subtle abnormalities in neuroepithelial precursors 2 and central nervous system architecture, 6 respectively, indicating that the Tf cycle may be important for neuronal development.
There are limitations to the conclusions that can be drawn from these studies of TfR -/-and Samples were incubated on ice for 10 min, then washed in 2% FCS/PBS and centrifuged as before. The pellets were resuspended in a small amount of the remaining liquid and 10,000 to 50,000 cells were counted for flow cytometry. Lymphocytes were identified by forward and side light scatter characteristics. 10,000 cells were counted from blood, and at least 100,000 cells were counted from thymus, spleen, and lymph nodes when there was enough material present. All antibodies were obtained from Pharmingen. All flow cytometry was performed on a FACSCalibur machine (Becton Dickson) using CellQuest software (BD Biosciences) and analyzed with FlowJo software (Tree Star, Inc.).
MATERIALS AND METHODS

Generation of TfR
RESULTS
Generation of TfR -/-ES cells and analysis of C57BL/6J chimeras
We chose a chimera approach for this study, reasoning that adult tissues that were not populated with TfR-null cells must require transferrin receptor for their development. Two independent,
homozygous TfR -/-ES clones (E12 and H5) were isolated using a neomycin "step-up" selection strategy on heterozygous parental TfR +/-ES cells (Fig.1A) . These TfR -/-ES clones were used in only.
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Results from our analysis of hematopoietic tissues were different from those of nonhematopoietic tissues. As expected, we found that control TfR +/-cells could also contribute substantially to bone marrow, spleen and thymus (Fig. 2B ). However, with the exception of one highly chimeric animal (estimated 85% from coat color), none of the chimeras produced from TfR -/-ES cells showed any detectable contribution of TfR -/-cells to those hematopoietic tissues (Fig. 2) . The ~85% chimera did show a very small contribution of TfR -/-cells to spleen and thymus, but not bone marrow (data not shown). This suggests that the spleen and thymus chimerism seen in this animal may be due to stromal and/or epithelial cells.
The fact that TfR -/-cells were not detected in the bone marrow in any C57BL/6J chimeras suggested that most, if not all, hematopoietic cells (or a hematopoietic stem cell) were dependent upon TfR for their proliferation and/or differentiation. This conclusion is further supported by the fact that thymus and spleen, both populated primarily by hematopoietic cells, also showed little or no contribution of TfR -/-cells. In the remainder of our analysis we focused on the role of TfR in lymphopoiesis.
only.
For Consequently, this system allows for a more sensitive analysis of lymphocyte development from modified ES cells than can be achieved on a wild type genetic background.
Chimeras were identified by Southern blot analysis of tail DNA taken at 18 to 26 days of age.
Chimerism assessed in this way ranged from ~10-50% (data not shown). Flow cytometry was performed on blood samples taken at the same time, to detect T and B lymphocytes in the circulation. Anti-Ly9.1 antibody recognizes an allele of a surface glycoprotein antigen present on strain 129 lymphocytes but absent from our RAG2 -/-cells, which display the C57BL/6 strain Ly9.2 specificity 11-13 . This difference permits the identification of lymphocytes derived from the injected ES cells. Two chimeras produced by blastocyst injection of parental TfR +/-ES cells showed full reconstitution of the mature, circulating lymphocyte pool, rescuing the defect in lymphocyte development seen in RAG2 -/-mice (Fig. 3) . In contrast, although 10,000 to 50,000
For 
DISCUSSION
We extended our previous analysis 2 to ask whether TfR is necessary for adult erythropoiesis and for the development of other adult tissues. Adult TfR -/-chimeras produced on a wild type C57BL/6J background showed contribution of TfR -/-cells to all tissues tested except those of hematopoietic origin--bone marrow, spleen, and thymus. We conclude that most cell types are capable of assimilating iron through a mechanism that is not mediated by TfR.
At least four TfR-independent iron acquisition pathways have been characterized in mammalian systems. TfR-independent uptake of Tf-bound iron has been noted in TfR-deficient CHO cells. 14, 15 Low level, receptor-mediated uptake of ferritin has been shown in human erythroid precursors. [16] [17] [18] Non-Tf-bound iron has been shown to be taken up directly by a variety of cell types in vitro, [19] [20] [21] [22] [23] in accord with the observation that apotransferrinemic patients and Tf hpx/hpx mice develop systemic iron overload in non-hematopoietic tissues. 4, 5, 24, 25 Most recently, iron delivery and uptake mediated by 24p3/NGAL (neutrophil gelatinase-associated lipocalin) has only.
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